ConforMIS Inc. (NASDAQ:CFMS) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), ConforMIS Inc. (NASDAQ:CFMS) reported that Aeris Capital Archer L.p. has picked up 1,480,349 of common stock as of 2017-04-12.
The acquisition brings the aggregate amount owned by Aeris Capital Archer L.p. to a total of 1,480,349 representing a 3.4% stake in the company.
For those not familiar with the company, ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient’s anatomy. The Company’s iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient’s knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.
A glance at ConforMIS Inc. (NASDAQ:CFMS)’s key stats reveals a current market capitalization of 223.92 Million based on 43.82 Million shares outstanding and a price at last close of $5.14 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-05-17, Law picked up 1,600 at a purchase price of $6.20. This brings their total holding to 24,793 as of the date of the filing.
On the sell side, the most recent transaction saw Steines unload 5,000 shares at a sale price of $5.00. This brings their total holding to 195,745.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on ConforMIS Inc. (NASDAQ:CFMS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Patton Thomas M is Buying Cas Medical Systems Inc. (NASDAQ:CASM) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cas Medical Systems Inc. (NASDAQ:CASM) reported that Patton Thomas M has picked up 1,623,389 of common stock as of 2017-04-04.
The acquisition brings the aggregate amount owned by Patton Thomas M to a total of 1,623,389 representing a 5.6% stake in the company.
For those not familiar with the company, CAS Medical Systems, Inc. is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales. It operates through two categories of sales: Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories, and Traditional Monitoring, which includes sales of its legacy products comprising the original equipment manufacturer (OEM) sales of its non-invasive blood pressure technology (MAXNIBP and MAXIQ), and monitor service and repair. The FORE-SIGHT Tissue Oximeter technology provides clinicians a non-invasive, quantitative measurement of oxygenation in cerebral tissue.
A glance at Cas Medical Systems Inc. (NASDAQ:CASM)’s key stats reveals a current market capitalization of 40.65 Million based on 28.23 Million shares outstanding and a price at last close of $1.46 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-05-28, Novelly picked up 500 at a purchase price of $1.25. This brings their total holding to 5,400 as of the date of the filing.
On the sell side, the most recent transaction saw Flynn unload 517,450 shares at a sale price of $1.46. This brings their total holding to 2,358,636.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Cas Medical Systems Inc. (NASDAQ:CASM) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Broadfin Capital Picked Up Alphatec Holdings Inc. (NASDAQ:ATEC) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Alphatec Holdings Inc. (NASDAQ:ATEC) reported that has picked up 1,164,618 of common stock as of 2017-03-29.
The acquisition brings the aggregate amount owned by Broadfin Capital to a total of 1,164,618 representing less than 9.99% stake in the company.
For those not familiar with the company, Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.
A glance at Alphatec Holdings Inc. (NASDAQ:ATEC)’s key stats reveals a current market capitalization of 21.89 Million based on 8.81 Million shares outstanding and a price at last close of $2.40 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-16, Cross picked up 15,000 at a purchase price of $4.25. This brings their total holding to 65,443 as of the date of the filing.
On the sell side, the most recent transaction saw Foster unload 1,033 shares at a sale price of $5.25. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Alphatec Holdings Inc. (NASDAQ:ATEC) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Entellus Medical Inc. (NASDAQ:ENTL) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Entellus Medical Inc. (NASDAQ:ENTL) reported that Discovery Group I, Llc. has picked up 1,638,127 of common stock as of 2017-03-14.
The acquisition brings the aggregate amount owned by Discovery Group I, Llc. to a total of 1,638,127 representing a 7.5% stake in the company.
For those not familiar with the company, Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company’s XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.
A glance at Entellus Medical Inc. (NASDAQ:ENTL)’s key stats reveals a current market capitalization of 285.18 Million based on 21.88 Million shares outstanding and a price at last close of $13.10 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-02-03, Split picked up 352,941 at a purchase price of $17.00. This brings their total holding to 3,156,731 as of the date of the filing.
On the sell side, the most recent transaction saw Essex unload 16,521 shares at a sale price of $17.00. This brings their total holding to 91,808.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Entellus Medical Inc. (NASDAQ:ENTL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Entellus Medical Inc. (NASDAQ:ENTL) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Entellus Medical Inc. (NASDAQ:ENTL) reported that Discovery Group I, Llc. has picked up 1,418,715 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by Discovery Group I, Llc. to a total of 1,418,715 representing a 6.5% stake in the company.
For those not familiar with the company, Entellus Medical, Inc. is a medical technology company. The Company is focused on the design, development and commercialization of products for the minimally invasive treatment of patients who are suffering from chronic sinusitis. The Company’s XprESS family of products is used by ear, nose and throat (ENT) physicians to treat patients with symptomatic inflammation of the nasal sinuses by opening narrowed or obstructed sinus drainage pathways using balloon sinus dilation. The Company’s XprESS family of products is used to treat patients with inflammation of the frontal, ethmoid, sphenoid and maxillary sinuses. Its XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The Company’s PathAssist tools provide ENT physicians with a way to confirm sinus location and XprESS device placement. Its FocESS Sinuscopes provide ENT physicians with a solution for endoscopic visualization during a sinus procedure.
A glance at Entellus Medical Inc. (NASDAQ:ENTL)’s key stats reveals a current market capitalization of 286.30 million based on 21.88 Million shares outstanding and a price at last close of $13.32 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-02-03, Split picked up 352,941 at a purchase price of $17.00. This brings their total holding to 3,156,731 as of the date of the filing.
On the sell side, the most recent transaction saw Essex unload 16,521 shares at a sale price of $17.00. This brings their total holding to 91,808.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Entellus Medical Inc. (NASDAQ:ENTL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Sawyer Philip M. Picked Up Invuity Inc. (NASDAQ:IVTY) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Invuity Inc. (NASDAQ:IVTY) reported that Sawyer Philip M. has picked up 788,444 of common stock as of 2017-02-14.
The acquisition brings the aggregate amount owned by Sawyer Philip M. to a total of 788,444 representing a 4.5% stake in the company.
For those not familiar with the company, Invuity is a medical technology company focused on pioneering the use of advanced photonics to provide surgeons with improved direct visualization of surgical cavities during open minimally invasive and minimal access procedures. The patented Intelligent Photonics technology enables superior illumination and visualization and is designed to overcome the significant limitations of traditional surgical lighting options in the operating room. Our patented Intelligent Photonics is integrated into our single-use and reusable advanced surgical devices to address some of the critical intracavity illumination and visualization challenges facing surgeons today. These devices utilize our proprietary optical waveguide technology to direct and shape thermally cool, brilliant light into broad, uniform and volumetric illumination of the surgical target.
A glance at Invuity Inc. (NASDAQ:IVTY)’s key stats reveals a current market capitalization of 116.82 million based on 16.93 million shares outstanding and a price at last close of $6.95 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-08, Mackaness picked up 1,700 at a purchase price of $5.75. This brings their total holding to 3,700 as of the date of the filing.
On the sell side, the most recent transaction saw Flynn unload 45,568 shares at a sale price of $6.01. This brings their total holding to 1,690,498.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Invuity Inc. (NASDAQ:IVTY) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Integra Lifesciences Holdings Corp. (NASDAQ:IART) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Integra Lifesciences Holdings Corp. (NASDAQ:IART) reported that Caruso Richard E. has picked up 6,201,027 of common stock as of 2017-02-13.
The acquisition brings the aggregate amount owned by Caruso Richard E. to a total of 6,201,027 representing a 16.57% stake in the company.
For those not familiar with the company, Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties. Its product category includes products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care, including product portfolios used in neurosurgery operation suites and critical care units, and Orthopedics and Tissue Technologies, which offers products of a combination of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities.
A glance at Integra Lifesciences Holdings Corp (NASDAQ:IART)’s key stats reveals a current market capitalization of 3.20 billion based on 74.77 million shares outstanding and a price at last close of $42.90 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2011-11-02, Caruso picked up 2,000 at a purchase price of $28.46. This brings their total holding to 2,000 as of the date of the filing.
On the sell side, the most recent transaction saw Arduini unload 20,000 shares at a sale price of $80.02. This brings their total holding to 25,593.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Integra Lifesciences Holdings Corp. (NASDAQ:IART) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.